ClinicalTrials.govpublic full text
Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate
rheumatoid arthritis, autoimmune diseases, musculoskeletal diseases, joint diseases, arthritis, connective tissue diseases, arthritis, rheumatoid, rheumatic diseases, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 899639
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.